Budget Amount *help |
¥4,550,000 (Direct Cost: ¥3,500,000、Indirect Cost: ¥1,050,000)
Fiscal Year 2026: ¥650,000 (Direct Cost: ¥500,000、Indirect Cost: ¥150,000)
Fiscal Year 2025: ¥390,000 (Direct Cost: ¥300,000、Indirect Cost: ¥90,000)
Fiscal Year 2024: ¥3,510,000 (Direct Cost: ¥2,700,000、Indirect Cost: ¥810,000)
|
Outline of Research at the Start |
GABA aminotransferase (GABA-T) is a GABA-degrading enzyme highly expressing in the brain and the liver. Previously, we found that a combination of dietary GABA and GABA-T inhibitor (vigabatrin (Vig)) significantly increased blood GABA levels and suppressed food intake. We hypothesized that elevated blood GABA is possibly a key factor mediating food intake suppression. Since Vig can get into the brain and regulates appetite there, in the present study, we aimed to determine if the inhibition of GABA-T only in the liver can exhibit the food-intake suppressive effect.
|